A role for transient receptor potential vanilloid 4 in tonicity‐induced neurogenic inflammation
Open Access
- 10 March 2010
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 159 (5) , 1161-1173
Abstract
Background and purpose: Changes in extracellular fluid osmolarity, which occur after tissue damage and disease, cause inflammation and maintain chronic inflammatory states by unknown mechanisms. Here, we investigated whether the osmosensitive channel, transient receptor potential vanilloid 4 (TRPV4), mediates inflammation to hypotonic stimuli by a neurogenic mechanism.Experimental approach: TRPV4 was localized in dorsal root ganglia (DRG) by immunofluorescence. The effects of TRPV4 agonists on release of pro‐inflammatory neuropeptides from peripheral tissues and on inflammation were examined.Key results: Immunoreactive TRPV4 was detected in DRG neurones innervating the mouse hindpaw, where it was co‐expressed in some neurones with CGRP and substance P, mediators of neurogenic inflammation. Hypotonic solutions and 4α‐phorbol 12,13‐didecanoate, which activate TRPV4, stimulated neuropeptide release in urinary bladder and airways, sites of neurogenic inflammation. Intraplantar injection of hypotonic solutions and 4α‐phorbol 12,13‐didecanoate caused oedema and granulocyte recruitment. These effects were inhibited by a desensitizing dose of the neurotoxin capsaicin, antagonists of CGRP and substance P receptors, and TRPV4 gene knockdown or deletion. In contrast, antagonism of neuropeptide receptors and disruption of TRPV4 did not prevent this oedema. TRPV4 gene knockdown or deletion also markedly reduced oedema and granulocyte infiltration induced by intraplantar injection of formalin.Conclusions and implications: Activation of TRPV4 stimulates neuropeptide release from afferent nerves and induces neurogenic inflammation. This mechanism may mediate the generation and maintenance of inflammation after injury and during diseases, in which there are changes in extracellular osmolarity. Antagonism of TRPV4 may offer a therapeutic approach for inflammatory hyperalgesia and chronic inflammation.Keywords
This publication has 53 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Protease‐activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in miceThe Journal of Physiology, 2007
- Tachykinins and tachykinin receptors: effects in the genitourinary tractLife Sciences, 2005
- Neurogenic mechanisms in bronchial inflammatory diseasesAllergy, 2004
- Colitis induced by proteinase-activated receptor-2 agonists is mediated by a neurogenic mechanismCanadian Journal of Physiology and Pharmacology, 2003
- Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant diseaseJournal of Internal Medicine, 1995
- Release of sensory CGRP by hypertonic NaCl is not blocked by tetrodotoxin, ω-conotoxin, nifedipine and ruthenium redLife Sciences, 1992
- Motor and inflammatory effect of hyperosmolar solutions on the rat urinary bladder in relation to capsaicin-sensitive sensory nervesGeneral Pharmacology: The Vascular System, 1990
- Neurogenic inflammation in the rat trachea. I. Changes in venules, leucocytes and epithelial cellsJournal of Neurocytology, 1988
- Hypertonic KCI, NaCI and capsaicin intracamerally causes release of substance P‐like immunoreactive material into the aqueous humor in rabbitsActa Physiologica Scandinavica, 1984